Nephrology Dialysis Transplantation (NEPHROL DIAL TRANSPL)

Publications in this journal

• Article: Lopot F: Is Urea Kinetic Modelling an Appropriate Tool for Guiding Ultrashort High-Flux Dialysis Therapy?, Nephrol. Dial. Transpl., Supl. 3, 1991, 86-87

  Lopot F
  Nephrology Dialysis Transplantation 02/2013; 6(Suppl. 3):86-87.
• Article: Lopot F, Válek A: Time-averaged Concentration - Time-averaged Deviation: A New Concept in Mathematical Assessment of Dialysis Adequacy, Nephrol. Dial. Transpl., 3, 1988, 846-848

  Lopot F, Válek A
  Nephrology Dialysis Transplantation 02/2013; 3(1998):846-848.
• Article: - Lopot F, Valek A: Quantification of Dialysis Unphysiology, Nephrol. Dial. Transpl., 13, 1998, S6, 74-78

  Lopot F, Válek A
  Nephrology Dialysis Transplantation 02/2013; 13(Supplement 6):74-78.
• Article: - Horáček J, Dusilová-Sulková S, Fořtová M, Lopot F, Kalousová M, Chaloupka J, Tesař V, Sobotka L, Zima T: Resting energy expenditure and thermal balance during isothermic and thermoneutral hemodialysis: heat production does not explain increased body temperature during hemodialysis, Nephrol Dial Transpl, 22, 2007, 3553-3560

  Horáček J, Dusilová-Sulková S, Fořtová M, Lopot F, Kalousová M, Chaloupka J, Tesař V, Sobotka L, Zima T
  Nephrology Dialysis Transplantation 02/2013; 22:3553-3560.
• Article: Mesenchymal stem cells and kidney repair.

  Marina Morigi, Ariela Benigni
  Nephrology Dialysis Transplantation 01/2013; 28:788-793.
• Article: Editorial: Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence

  Marijn Speeckaert, Joris Delanghe, Raymond Vanholder
  Nephrology Dialysis Transplantation 01/2013;
• Article: Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

  Kielstein JT, Beutel G, Fleig S, Brunkhorst R
  Nephrology Dialysis Transplantation 10/2012;
• Article: Letter to editor: Barriers to exercise participation among dialysis patients

  Ali Jafarzadeh Esfehani, Sareh Dashti
  Nephrology Dialysis Transplantation 10/2012; 27(10):3964.
• Article: Crimean–Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure

  Mohammed Reza Ardalan, R. Shane Tubbs, Sadegh Chinikar4 and Mohammadali Mohajel Shoja
  Nephrology Dialysis Transplantation 05/2012;
• Article: Improving quality of life in patients with chronic kidney disease: influence of acceptance and personality

  Poppe C, Crombez G, Hanoulle I, Vogelaers D, Petrovic M
  Nephrology Dialysis Transplantation 01/2012;
• Article: Improving quality of life in patients with chronic kidney disease: influence of acceptance and personality

  Poppe
  Nephrology Dialysis Transplantation 01/2012;
• Article: Cold ischemia, innate immunity and deterioration of the glomerular filtration barrier in antibody-mediated acute rejection

  Ripoll E, Nacher V, Vidal A, Herrero E, Bolaños N, Torras J, Grinyó JM, Ruberte J
  Nephrology Dialysis Transplantation 01/2012;
• Article: Population Screening for Chronic Kidney Disease: a survey involving 38,721 Brazilians

  Altair O. Lima, Silvana Kesrouani, Rui A. Gomes, Jenner Cruz, Gianna Mastroianni Kirsztajn
  Nephrology Dialysis Transplantation 01/2012;
• Article: Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation.

  Höcker B, Weber LT, Feneberg R, Drube J, John U, Fehrenbach H, Pohl M, Zimmering M, Fründ S, Klaus G, Wühl E, Tönshoff B
  [show abstract] [hide abstract]
  ABSTRACT: BACKGROUND: Long-term corticosteroid treatment impairs growth and increases cardiovascular risk factors. Hence, steroid withdrawal constitutes a major topic in paediatric renal transplantation and maintenance immunosuppression. METHODS: The lack of data from randomised controlled trials caused us to conduct the first prospective, randomised, multicentre study on late steroid withdrawal among paediatric kidney allograft recipients treated with standard-dose cyclosporine microemulsion (CsA) and mycophenolate mofetil (MMF) for 2 years. Forty-two low- or regular-immunologic risk patients were randomly assigned, >or=1 year post-transplant, to continue taking or to withdraw steroids over 3 months. RESULTS: Two years after steroid withdrawal, they showed a longitudinal growth superior to controls [mean height standard deviation score (SDS) gain, 0.6 +/- 0.1 SDS versus -0.2 +/- 0.1 SDS (P < 0.001)]. The prevalence of the metabolic syndrome declined significantly (P < 0.05), 2 years after steroid withdrawal, from 39% (9/23) to 6% (1/16). Steroid-free patients had less frequent arterial hypertension (50% versus 93% (P < 0.05)) and required fewer antihypertensive drugs [0.6 +/- 0.2 versus 1.5 +/- 0.3 (P < 0.05 versus control)]. Additionally, they had a significantly improved carbohydrate and lipid metabolism with fewer hypercholesterolaemia and hypertriglyceridaemia (P < 0.05 versus control). Patient and graft survival amounted to 100%. Allograft function remained stable 2 years after steroid withdrawal. The incidence of acute rejections was similar in the steroid-withdrawal group (1/23, 4%) and controls (2/19, 11%). CONCLUSION: Late steroid withdrawal in selected CsA- and MMF-treated paediatric kidney transplant recipients improves growth, mitigates cardiovascular risk factors and reduces the prevalence of the metabolic syndrome, at no increased risk of acute rejection or unstable graft function.
  Nephrology Dialysis Transplantation 02/2010;